NICHOLAS RILEY: Open Payments
NPI 1730702796 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 12 payments from 10 companies in 2025. Trend: 2023 $276 · 2024 $399 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| Medtronic, Inc. | 1 | $47 |
| Boston Scientific Corporation | 1 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: MYCARELINK, QULIPTA, Axonics, VRAYLAR, Kerendia, Veozah, REXULTI, EVENITY.
Industry payments across CO — which companies pay providers there.
